$3.13-0.23 (-6.85%)
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid.
Hyperion DeFi, Inc. in the Healthcare sector is trading at $3.13 with a market capitalization of $51M. Wall Street consensus targets $9.82 (2 analysts), implying a +213.9% move over the next 12 months. The stock is currently near its 52-week low of $2.34, remaining 7.7% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $357,693β | $244,271β | $496,229β | $302,506 | $0 |
| Gross Profit | $357,693β | $244,271β | $192,987β | $302,506 | $0 |
| Operating Income | -$2.71Mβ | -$5.04Mβ | -$4.93Mβ | -$2.67Mβ | -$8.35M |
| Net Income | $30.95Mβ | $8.84Mβ | -$39.77Mβ | $6.63Mβ | -$8.69M |
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure...